Article Versions Notes

Kern A, Stompór T, Kiewisz J, Kraziński BE, Kiezun J, Kiezun M, Górny J, Sienkiewicz E, Gromadziński L, Onichimowski D, et al. The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-Up. Journal of Personalized Medicine. 2021; 11(3):186. https://doi.org/10.3390/jpm11030186

Kern, Adam, Tomasz Stompór, Jolanta Kiewisz, Bartłomiej E. Kraziński, Jacek Kiezun, Marta Kiezun, Jerzy Górny, Ewa Sienkiewicz, Leszek Gromadziński, Dariusz Onichimowski, and et al. 2021. "The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-Up" Journal of Personalized Medicine 11, no. 3: 186. https://doi.org/10.3390/jpm11030186

Kern, A., Stompór, T., Kiewisz, J., Kraziński, B. E., Kiezun, J., Kiezun, M., Górny, J., Sienkiewicz, E., Gromadziński, L., Onichimowski, D., & Bil, J. (2021). The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-Up. Journal of Personalized Medicine, 11(3), 186. https://doi.org/10.3390/jpm11030186